Company / Current Assets per Share
Beam Therapeutics Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$12.47
FY2025
5-year range
$10.50 / $18.61
FY2021-FY2025
Trend
+18.8%
vs FY2024
Sector context
#56 of 210
Health Care
What the data says
At $12.47, Beam Therapeutics Inc.'s current assets per share ranks #56 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $12.47.
Based on SEC 10-K filings.
12.47 in FY2025 with a 5-year CAGR of -21.6%.
Declined from $14.84 to $12.47 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.7%
- 5-Year CAGR
- -21.6%
- 10-Year CAGR
- -
Sector benchmark
#56 of 210 in Health CareTop 27% of 210This company $12.47 Sector average $170.65
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 18.8% year-over-year.
- Ranks #56 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.47 | +18.8% |
| FY2024 | $10.50 | -29.2% |
| FY2023 | $14.84 | -3.2% |
| FY2022 | $15.33 | -17.6% |
| FY2021 | $18.61 | -55.8% |
| FY2020 | $42.08 | +188.4% |
| FY2019 | $14.59 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026